Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew history entry dated 2026-08-06 adds a Study Status update and records revision v3.6.5 for the study record. This reflects ongoing maintenance of the official history and the current status of the trial.SummaryDifference0.4%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision label, v3.6.4, appears in the page history. This represents an updated version of the study record page and does not modify the underlying study data.SummaryDifference0.1%

- Check45 days agoChange DetectedNew Study Status entry added to the record history on 2026-07-06, with an associated data point on 2026-06-16. An earlier history entry dated 2026-05-29 was removed, affecting the timeline shown for the trial.SummaryDifference0.3%

- Check52 days agoChange DetectedA new revision entry v3.6.3 was added to the study's version history and the previous v3.6.2 entry was removed. This updates the historical record to reflect the latest revision state of the study documentation.SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision history shows a new release tag (v3.6.2), replacing the prior v3.6.0. This indicates a software update to the page rather than substantive changes to the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe history shows the study is no longer recruiting participants, and the record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.